<?xml version="1.0" encoding="UTF-8"?>
<p>Other similar investigations may be envisioned with respect to the increasing identifications of the importance of CoVs as a driving force of COVID-19. Apart from the potential progression of RDV for treating SARS- and MERS-CoVs, the emergence of other viral illnesses may pave the way for clinical trials of RDV derivatives.</p>
